3,592
Participants
Start Date
October 31, 2004
Primary Completion Date
October 31, 2005
Study Completion Date
Treatment
were receiving an oral hypoglycemic agent (OHA) or insulin
Lead Sponsor
GlaxoSmithKline
INDUSTRY